Determining risk of ocular damage from chronic intravitreal injections
Because these injections have been used for a relatively short period, the definitive consequences of chronic use remain to be determined.
Learn more
 
Innovations from enucleation: Where can we go from here?
Ocular enucleation is inevitable for some patients; but for others, new therapies might spare the eye. If it must happen, there are ways to ease that road for patients.
Read more
ADVERTISEMENT
 
Blockchain technology aims to drive big data to ‘train’ AI
Artificial Intelligence is the subject of numerous articles that tout how well machines function better than human ophthalmologists, but why is this happening?
Read more
ADVERTISEMENT
Glaucoma: arm patients with the facts
More than anything, your patients need to understand glaucoma's risks, symptoms, consequences and therapies. This Ophthalmology Times® resource center features the latest institutional knowledge, treatment technologies and peer perspectives. Help boost glaucoma awareness now.
 
 
RELATED ARTICLES
 
The dropless future: SLT as a first-line treatment for glaucoma
Pharmacologic treatment an option for open-angle glaucoma
Genetics analysis may predict myopia in children
Putting technologies into practice not perfect science
Diagnosing LSCD noninvasively: SD-OCT preferred technology
Researchers eye cure, diagnostics for adenoviral conjunctivitis
Fluorescein angiography key in diagnosing retinal diseases
Corneal ectasia: Effects of epi-on and epi-off CXL